Suchergebnisse - "Aksoydan, Busecan"

PubPharm (31)

1

A NOVEL MAO-B INHIBITOR DRG-MAOB-1 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES

enthalten in: Europäisches Patentamt | 2023

von DURDAGI SERDAR | YURTSEVER MINE DIDEM | AKSOYDAN BUSECAN | +2

2

A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES

enthalten in: Europäisches Patentamt | 2023

von DURDAGI SERDAR | YURTSEVER MINE DIDEM | IS YUSUF SERHAT | +2

3

Molecular simulations reveal the impact of RAMP1 on ligand binding and dynamics of CGRPR heterodimer

enthalten in: bioRxiv.org | 2022

von Aksoydan, B. | Durdagi, S.

4

Virtual drug repurposing study for the CGRPR identifies pentagastrin and leuprorelin as putative candidates

enthalten in: Journal of molecular graphics & modelling | 2022

von Aksoydan, B. | Durdagi, S.

5

Molecular simulations reveal the impact of RAMP1 on ligand binding and dynamics of calcitonin gene-related peptide receptor (CGRPR) heterodimer

enthalten in: Computers in biology and medicine | 2022

von Aksoydan, B. | Durdagi, S.

6

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 : A Combined in silico and in vitro Study

enthalten in: Molecular informatics | 2022

von Durdagi, S. | Orhan, M. | Aksoydan, B. | +6

7

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2 : A Combined in silico and in vitro Study

enthalten in: Molecular Informatics | 2022

von Durdagi, S. | Orhan, M. | Aksoydan, B. | +6

8

Near-Physiological-Temperature Serial Femtosecond X-ray Crystallography Reveals Novel Conformations of SARS-CoV-2 Main Protease Active Site for Improved Drug Repurposing

enthalten in: bioRxiv.org | 2021

von Durdagi, S. | Dag, C. | Dogan, B. | +46

9

Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing

enthalten in: Structure (London, England : 1993) | 2021

von Durdagi, S. | Dağ, �. | Dogan, B. | +46

10

Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study

enthalten in: chemRxiv.org | 2021

von Durdagi, S. | Aksoydan, B. | Dogan, B. | +3